Kezar Life Sciences KZR

$ 6.46 -0.92%

Quarterly report 2024-Q3
added 11-12-2024

Kezar Life Sciences Financial Statements 2011-2024 | KZR

Annual Financial Statements Kezar Life Sciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	61.7 M	348 M	783 M	241 M	52.9 M	177 M	-	3.66 M	-	-	-	-	-
Shares	72.6 M	67.4 M	52.8 M	44 M	19.1 M	10.3 M	-	18.3 M	-	-	-	-	-
Historical Prices	0.85	5.16	14.8	5.48	4.38	20.4	-	-	-	-	-	-	-
Net Income	-102 M	-68.2 M	-54.6 M	-41.7 M	-35.1 M	-23.2 M	-8.52 M	-8.99 M	-	-	-	-	-
Revenue	7 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-111 M	-71.2 M	-54.7 M	-43 M	-37.3 M	-24.7 M	-8.75 M	-8.99 M	-	-	-	-	-
Interest Expense	1.55 M	1.18 M	159 K	-	-	-	-	-	-	-	-	-	-
EBITDA	-110 M	-70.1 M	-53.1 M	-41.4 M	-36 M	-24 M	-8.57 M	-8.84 M	-	-	-	-	-
Operating Expenses	118 M	71.2 M	54.7 M	43 M	37.3 M	24.7 M	-	-	-	-	-	-	-
General and Administrative Expenses	26.5 M	20.2 M	15.7 M	12 M	9.98 M	6.59 M	2.28 M	1.62 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Kezar Life Sciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	7.3 M	72.8 M	72.8 M	7.28 M	7.27 M	72.5 M	72.3 M	68.5 M	72.2 M	64.3 M	60.6 M	56.3 M	52 M	51.9 M	51.1 M	46.4 M	50 M	42.9 M	32.9 M	19.2 M	19.1 M	19.1 M	19 M	19.1 M	19 M	2.04 M	757 K	949 K	628 K	569 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-20.3 M	-21.5 M	-21.7 M	-	-23.1 M	-24.3 M	-22.2 M	-	-17.8 M	-16.2 M	-16 M	-	-14.5 M	-13 M	-13 M	-10.9 M	-11.3 M	-9.5 M	-10 M	-9.58 M	-9.15 M	-8.72 M	-7.64 M	-5.78 M	-5.66 M	-6.78 M	-4.95 M	-2.3 M	-2.08 M	-1.88 M	-2.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-21.9 M	-23.4 M	-23.7 M	-	-25.5 M	-26.8 M	-24.5 M	-	-18.9 M	-16.3 M	-15.9 M	-	-14.5 M	-13 M	-13 M	-	-11.6 M	-9.85 M	-10.5 M	-	-9.68 M	-9.36 M	-8.31 M	-	-6.26 M	-6.95 M	-5.09 M	-	-2.19 M	-1.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	403 K	401 K	400 K	-	396 K	385 K	370 K	-	310 K	272 K	254 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-21.6 M	-23.1 M	-23.5 M	-	-25.2 M	-26.6 M	-24.3 M	-	-18.6 M	-16.1 M	-15.5 M	-	-13.4 M	-12.3 M	-12.7 M	-	-10.4 M	-9.12 M	-10.1 M	-	-8.72 M	-8.73 M	-8.01 M	-	-5.78 M	-6.67 M	-5 M	-	-2.06 M	-1.79 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	21.9 M	23.4 M	23.7 M	-	32.5 M	26.8 M	24.5 M	-	18.9 M	16.3 M	15.9 M	-	14.5 M	13 M	13 M	11.1 M	11.6 M	9.85 M	10.5 M	10 M	9.68 M	9.36 M	8.31 M	6.43 M	6.26 M	6.95 M	5.09 M	2.42 M	2.19 M	1.88 M	2.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.71 M	5.6 M	6.54 M	-	8.79 M	5.78 M	6.21 M	-	5.07 M	4.98 M	4.93 M	-	3.97 M	3.67 M	3.76 M	-	3.29 M	2.7 M	3.02 M	-	2.6 M	2.43 M	2.38 M	-	1.6 M	1.72 M	1.51 M	-	635 K	436 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency